Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (ACCD)
NASDAQ:ACCD
Accolade (ACCD) Stock Price & Analysis
374 Followers
ACCD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.48 - $15.36
Previous Close$3.61
Volume1.43M
Average Volume (3M)1.17M
Market Cap
$288.83M
Enterprise Value$298.79M
Total Cash (Recent Filing)$230.64M
Total Debt (Recent Filing)$240.59M
Price to Earnings (P/E)―
Beta2.06
Next Earnings
Oct 03, 2024EPS Estimate
-$0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding78,356,908
10 Day Avg. Volume774,954
30 Day Avg. Volume1,165,668
Standard Deviation0.22
R-Squared0.23
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)257.69
Price to Sales (P/S)3.85
Price to Cash Flow (P/CF)20.20
P/FCF Ratio31.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit1.56
Enterprise Value/Ebitda-7.73
Forecast
1Y Price Target
$7.90Price Target Upside118.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Accolade News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe quarter beat consensus, both on the top-line and EBITDA lines, aided in large part by early revenue recognition.
Market PositionAccolade is well positioned in a navigation market that remains one of the most attractive opportunities in digital health.
Revenue GrowthShares are at all-time lows while the revenue base has diversified and grown 50%+ over the last two years.
Bears Say
Competitive PressuresThere are several entities such as Quantum Health, Included Health, Transcarent, and Sharecare, all of which compete in the space to some extent.
Growth OutlookPlushCare growth is now expected to be ~20% for FY25 vs. mid-to-high 20’s prior.
Revenue GuidanceAccolade lowered FY25 revenue guidance by 5% and maintained its EBITDA outlook helped by cutting opex.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ACCD FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was $3.48 and its highest was $15.36 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Oct 03, 2024 which is in 87 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Jun 27, 2024. The company reported -$0.35 earnings per share for the quarter, beating the consensus estimate of -$0.48 by $0.13.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is -$0.44.
How many shares outstanding does Accolade have?
Accolade has 80,008,380 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -$0.35 in its last earnings report, beating expectations of -$0.48. Following the earnings report the stock price went down -43.975%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 59M.
---
Accolade Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.90 (118.84% Upside)
$7.90 (118.84% Upside)
Blogger Sentiment
Bullish
ACCD Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.3%
Last 30 Days ▲ 9.5%
Last 30 Days ▲ 9.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.61%
12-Months-Change
Fundamentals
Return on Equity
-20.01%
Trailing 12-Months
Asset Growth
-12.37%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
ACCD Company Deck
---
ACCD Earnings Call
Q1 2024
0:00 / 0:00
---
ACCD Stock 12 Month Forecast
Average Price Target
$7.90
▲(118.84% Upside)
Technical Analysis
Best Analysts Covering ACCD
1 Year
1 Year Success Rate
5/18 ratings generated profit
1 Year Average Return
-22.71%
reiterated a buy rating 11 days ago
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 27.78% of your transactions generating a profit, with an average return of -22.71% per trade.
---